Australia markets closed

Salarius Pharmaceuticals, Inc. (SLRX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4951+0.0141 (+2.93%)
At close: 04:00PM EDT
0.5100 +0.01 (+3.01%)
After hours: 05:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-12,543
-12,543
-31,608
-12,768
-7,352
Depreciation & amortisation
10.051
10.051
6.677
19.183
18.058
Stock-based compensation
524.838
524.838
796.803
559.044
319.391
Change in working capital
-968.333
-968.333
2,370
2,035
-3,038
Accounts receivable
-
-
-
-
0
Inventory
-
-
-
-
0
Accounts payable
-2,255
-2,255
1,313
-310.66
-2.782
Other working capital
-12,846
-12,846
-19,095
-10,200
-10,314
Other non-cash items
-
-
1,988
-
-
Net cash provided by operating activities
-12,846
-12,846
-17,595
-10,200
-10,311
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-1,500
-
-2.6
Net cash used for investing activities
0
0
-1,500
0
-2.6
Cash flows from financing activities
Debt repayment
-280.917
-280.917
0
-477.028
-974.435
Common stock issued
6,921
6,921
1,987
27,288
14,799
Dividends paid
-
-
-
-
0
Net cash used provided by (used for) financing activities
6,640
6,640
1,987
28,296
17,694
Net change in cash
-6,207
-6,207
-17,108
18,096
7,380
Cash at beginning of period
12,106
12,106
29,214
11,119
3,739
Cash at end of period
5,900
5,900
12,106
29,214
11,119
Free cash flow
Operating cash flow
-12,846
-12,846
-17,595
-10,200
-10,311
Capital expenditure
-
-
-1,500
-
-2.6
Free cash flow
-12,846
-12,846
-19,095
-10,200
-10,314